| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AAN Transforms Neurologist Challenges Into Opportunities for Improvement
|
Rizzo, Toni
|
|
2015
|
|
9 |
p. 2-3
|
article
|
| 2 |
A Comparison of the OGTT and Measurement of HbA1C Using the ADA 2010 Recommendations
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 36-36
|
article
|
| 3 |
Adalimumab Plus Methotrexate versus Methotrexate Monotherapy in Early RA
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 16-16
|
article
|
| 4 |
ADDITION Shows No Increased Benefit of Early Multifactorial Intensive Therapy
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 26-26
|
article
|
| 5 |
Adenosine-Guided Elimination of Dormant PV Conduction in Paroxysmal AF
|
Hitt, Emma
|
|
2014
|
|
9 |
p. 15-16
|
article
|
| 6 |
Adipose Tissue at the Crossroads of the Metabolic Syndrome
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 37-38
|
article
|
| 7 |
AF Patients with Contraindications to Oral Anticoagulation Therapy Treated Successfully with LAA
|
Vinall, Phil
|
|
2014
|
|
9 |
p. 16-16
|
article
|
| 8 |
American Academy of Neurology, 2015 Annual Meeting: Advisor’s Introduction
|
Leary, Megan C.
|
|
2015
|
|
9 |
p. i-i
|
article
|
| 9 |
Anti-TNF Therapy and CV Risk in RA
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 12-13
|
article
|
| 10 |
A2NTX an Effective Substitute for OnabotulinumtoxinA in Poststroke Spasticity
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 13-13
|
article
|
| 11 |
An Update on the DIGAMI Studies
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 25-26
|
article
|
| 12 |
Applying Genetic Discoveries to the Treatment of PD and Epilepsy
|
Summers, Jaye
|
|
2015
|
|
9 |
p. 29-30
|
article
|
| 13 |
Assessment and Treatment of Mitral Stenosis in Trinidad and Tobago
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 35-35
|
article
|
| 14 |
Association between Altered Lipid Profile and Uric Acid with Risk of MI in Patients in Trinidad and Tobago
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 23-24
|
article
|
| 15 |
AVP-825 Produces Effective, Well-Tolerated Migraine Relief
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 8-9
|
article
|
| 16 |
Baseline Features of Patients With RMS in Ocrelizumab Trials OPERA I and OPERA II
|
Summers, Jaye
|
|
2015
|
|
9 |
p. 14-14
|
article
|
| 17 |
BNP is a Predictor of Changes in LV Systolic and Diastolic Function Regardless of Diabetes Status
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 24-25
|
article
|
| 18 |
Brivaracetam Reduces Seizure Frequency in Patients With Partial-Onset Seizures
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 11-13
|
article
|
| 19 |
Candesartan Fails to Prevent Microalbuminuria in Hypertensive Diabetics When Stringent Criteria are Used
|
Keller, Dan
|
|
2010
|
|
9 |
p. 27-28
|
article
|
| 20 |
Cardiovascular Disease Impact in Rheumatic Disease
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 4-5
|
article
|
| 21 |
Clinical and Radiological Outcomes of Four DAS ≤2.4 Targeted Treatment Strategies: Eight-Year Results from the BeSt Study
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 18-19
|
article
|
| 22 |
Clinical Issues: Migraine Biomarkers, BP and Recurrent ICH, and Autism Genetics
|
Rizzo, Toni
|
|
2015
|
|
9 |
p. 26-28
|
article
|
| 23 |
COLM Results: Hypertensive Patients Aged ≥75 Years Have Better Clinical Outcomes and Fewer AEs on CCBs than Diuretics
|
Otrompke, John
|
|
2013
|
|
9 |
p. 8-8
|
article
|
| 24 |
Complications of Diabetes Have a Significant Long-Term Impact on QoL
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 19-22
|
article
|
| 25 |
CV Protection by Antihyperglycemic Drugs: Evidence from Clinical Trials
|
Mosely, Mary
|
|
2013
|
|
9 |
p. 14-15
|
article
|
| 26 |
DECIDE: Daclizumab HYP Superior to IFN-β-1a for Brain Lesion Activity in RRMS
|
Kuznar, Wayne
|
|
2015
|
|
9 |
p. 19-19
|
article
|
| 27 |
Defibrillators Programmed with Longer Detection Intervals Safe for Secondary Prevention Patients
|
Parry, Nicola
|
|
2014
|
|
9 |
p. 22-22
|
article
|
| 28 |
Depression and Antiepileptic Drug Use Do Not Affect Eslicarbazepine Efficacy in Patients With Partial-Onset Seizures
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 10-11
|
article
|
| 29 |
Determining Inter-Arm Blood Pressure is Important in New Patients with Diabetes
|
Cunningham, Muriel
|
|
2013
|
|
9 |
p. 11-11
|
article
|
| 30 |
Developments in Treatment of AHF
|
Hoyle, Brian
|
|
2014
|
|
9 |
p. 36-38
|
article
|
| 31 |
Diabetes and CVD: A Caribbean Perspective
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 26-27
|
article
|
| 32 |
Diabetes and the Bone
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 31-32
|
article
|
| 33 |
Disease Activity in Year 1 Predicts Long-term Outcomes in Patients Taking Fingolimod
|
Summers, Jaye
|
|
2015
|
|
9 |
p. 17-17
|
article
|
| 34 |
Early Treatment with Olmesartan Delays Progression of Nephropathy in Patients with Type 2 Diabetes
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 26-27
|
article
|
| 35 |
EASD/ADA Symposium: Provisional New WHO Diagnostic Criteria 2010
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 12-13
|
article
|
| 36 |
Echocardiographic Characteristics Not Predictive of One-Year Mortality in Patients Starting Hemodialysis
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 23-23
|
article
|
| 37 |
Effects of Renal Denervation on Endothelial Function, and Inflammatory and Metabolic Markers
|
Mosely, Mary
|
|
2013
|
|
9 |
p. 8-9
|
article
|
| 38 |
Efficacy and Safety of NNC0109-0012 (Anti-IL-20 mAb) in Patients with RA: Results from a Phase 2a Trial
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 9-10
|
article
|
| 39 |
Efficacy of Different Doses of Rituximab for the Treatment of RA: Data from the CERERRA Collaboration
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 11-12
|
article
|
| 40 |
Emerging Therapies and Their Role in Comprehensive Lipid Management
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 6-7
|
article
|
| 41 |
ENCOReD: Meta-Analysis of Renal Denervation in 10 European Expert Centers
|
Mosely, Mary
|
|
2013
|
|
9 |
p. 7-8
|
article
|
| 42 |
2013 ESH/ESC Guidelines Provide Updated Recommendations for Hypertension Management
|
Cunningham, Muriel
|
|
2013
|
|
9 |
p. 4-5
|
article
|
| 43 |
EULAR/ERA-EDTA Lupus Nephritis Recommendations
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 30-30
|
article
|
| 44 |
Evaluating the Asymptomatic Patient for CV Risk Factors
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 24-24
|
article
|
| 45 |
Evidence of Added Benefit with Edoxaban in Patients with Paroxysmal AF
|
Vinall, Maria
|
|
2014
|
|
9 |
p. 20-22
|
article
|
| 46 |
EXPEDITION EXT: Delayed-Start Analyses of Solanezumab in Patients With Mild AD
|
Summers, Jaye
|
|
2015
|
|
9 |
p. 15-17
|
article
|
| 47 |
Favorable Phase 2 Data for Ranolazine in AF
|
Parry, Nicola
|
|
2014
|
|
9 |
p. 24-25
|
article
|
| 48 |
FREEDOM Trial Analysis: Denosumab Discontinuation and Associated Fracture Incidence
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 28-28
|
article
|
| 49 |
Gestational Diabetes
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 29-30
|
article
|
| 50 |
Guidelines for the Management of Primary Systemic Vasculitis
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 29-29
|
article
|
| 51 |
How Have Registries Led to Advances in Cardiology?
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 14-15
|
article
|
| 52 |
Hypertension: What are Reasonable Goals for Therapy?
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 12-13
|
article
|
| 53 |
Idebenone Delays Respiratory Decline in Duchenne Muscular Dystrophy
|
Parry, Nicola
|
|
2015
|
|
9 |
p. 6-7
|
article
|
| 54 |
Inflammation and Fatty Degeneration in New Bone Formation in Patients with AS Treated with Anti-TNF Agents
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 19-20
|
article
|
| 55 |
Innovative Arrhythmia Technologies
|
Hoyle, Brian
|
|
2014
|
|
9 |
p. 28-29
|
article
|
| 56 |
INTERACT2 Results: Intensive BP Lowering Safe and Effective in Acute ICH Patients
|
Otrompke, John
|
|
2013
|
|
9 |
p. 9-10
|
article
|
| 57 |
Interview with the EULAR President
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 6-6
|
article
|
| 58 |
Is Obesity a Modifiable Risk Factor for AF?
|
Hoyle, Brian
|
|
2014
|
|
9 |
p. 26-27
|
article
|
| 59 |
Large Study Suggests That Death Comprises Higher Proportion of Major CV Events in Patients with Greater CV Risk
|
Otrompke, John
|
|
2013
|
|
9 |
p. 10-11
|
article
|
| 60 |
LDL Lowering with Statins in Diabetes
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 38-39
|
article
|
| 61 |
Levodopa-Carbidopa Intestinal Gel Shows Promise in Advanced Parkinson Disease
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 11-11
|
article
|
| 62 |
LITHE Study Subset: Identification of Tocilizumab Early Response-Associated Biomarkers
|
Buckley, Rita
|
|
2012
|
|
9 |
p. 15-15
|
article
|
| 63 |
Lung Ultrasound for Screening Interstitial Lung Disease
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 20-20
|
article
|
| 64 |
LVE Lead Placement Using a Superior Approach is Feasible and Safe
|
Vinall, Phil
|
|
2014
|
|
9 |
p. 13-14
|
article
|
| 65 |
Medical Device Safety: Addressing the Issues
|
Mosley, Mary
|
|
2014
|
|
9 |
p. 30-31
|
article
|
| 66 |
Meta-Analyses of ARBs to Elucidate Link to Cancer, MI, and Dementia
|
Cunningham, Muriel
|
|
2013
|
|
9 |
p. 16-16
|
article
|
| 67 |
Meta-Analysis of Hypertension Trials Confirms Benefits of Blood Pressure Lowering
|
Cunningham, Muriel
|
|
2013
|
|
9 |
p. 12-13
|
article
|
| 68 |
Minimally Invasive Cardiac Surgery
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 34-34
|
article
|
| 69 |
MODERATO Study to Assess the Effect of Rasagiline on Patients With Parkinson Disease and Mild Cognitive Impairment
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 9-9
|
article
|
| 70 |
MR CLEAN: Endovascular Therapy Improves Outcomes in Acute Ischemic Stroke
|
Parry, Nicola
|
|
2015
|
|
9 |
p. 7-8
|
article
|
| 71 |
Naïve to Biologic Therapy or Inadequate Responders to TNF-α Inhibitors: A Phase 2 Study of LY2439821
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 14-15
|
article
|
| 72 |
Neurologic Emergencies Require Rapid Plan of Action
|
Kuznar, Wayne
|
|
2015
|
|
9 |
p. 20-22
|
article
|
| 73 |
New and Standard Methods for the Prediction of Type 2 Diabetes Mellitus
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 16-17
|
article
|
| 74 |
New-Onset Diabetes after Transplantation
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 33-34
|
article
|
| 75 |
No Defibrillation Testing Best for ICD Implantation
|
Hitt, Emma
|
|
2014
|
|
9 |
p. 17-19
|
article
|
| 76 |
No Difference in Clinical Outcome between PCI and CABG in Patients with CAD
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 22-22
|
article
|
| 77 |
Noninsulin Antidiabetic Agents: Typical and Atypical Effects
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 34-35
|
article
|
| 78 |
One-Year Results from the AMPLE Study
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 7-7
|
article
|
| 79 |
Predictors of Ten-Year Survival following AMI in San Fernando, Trinidad
|
Buckely, Rita
|
|
2011
|
|
9 |
p. 20-21
|
article
|
| 80 |
Preventing Atrial Fibrillation
|
Nichols, Emma Hitt
|
|
2014
|
|
9 |
p. 6-8
|
article
|
| 81 |
Preventing Stroke in AF: Current Issues
|
Mosley, Mary
|
|
2014
|
|
9 |
p. 34-35
|
article
|
| 82 |
Promising and Feasible: Leadless Cardiac Pacing
|
Vinall, Maria
|
|
2014
|
|
9 |
p. 19-20
|
article
|
| 83 |
Ranolazine and Dronedarone in Combination Show Synergistic Effects on AF Suppression
|
Parry, Nicola
|
|
2014
|
|
9 |
p. 23-24
|
article
|
| 84 |
Recent Data from LEAD
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 18-19
|
article
|
| 85 |
Recent Developments in Valve Surgery
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 10-11
|
article
|
| 86 |
REFLEXION Trial: Delayed Treatment of First MS Event Increases Time to CDMS
|
Summers, Jaye
|
|
2015
|
|
9 |
p. 14-15
|
article
|
| 87 |
Results from the ESPOIR Cohort Study
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 16-17
|
article
|
| 88 |
RM of Implantable Cardiac Devices is Associated with Improved Survival
|
Nichols, Emma Hitt
|
|
2014
|
|
9 |
p. 16-17
|
article
|
| 89 |
Sleep Disorder Challenges, Diagnosis, and Treatments: Hypersomnolence and OSA
|
Rizzo, Toni
|
|
2015
|
|
9 |
p. 23-25
|
article
|
| 90 |
Small Molecules for Rheumatoid Arthritis
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 26-27
|
article
|
| 91 |
Smartphone-Enabled ECG Devices Produce Diagnostic Tracings in Children
|
Parry, Nicola
|
|
2014
|
|
9 |
p. 22-23
|
article
|
| 92 |
STAR CAST: Preliminary Results of Trial to Regress Hypertension
|
Mosely, Mary
|
|
2013
|
|
9 |
p. 6-6
|
article
|
| 93 |
Status Report: Cardiac Catheterization Project- Belize
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 33-33
|
article
|
| 94 |
Status Report: Heart Failure Registry 2011
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 15-17
|
article
|
| 95 |
Status Report: The West Indies Cardiac Surgery Registry
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 20-20
|
article
|
| 96 |
Stratifying Risk for Sudden Cardiac Death
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 8-9
|
article
|
| 97 |
Substrate-Based Ablation Reduces Recurrent Arrhythmia Compared to Focused Ablation in Ischemic Cardiomyopathy with Stable VT
|
Nichols, Emma Hitt
|
|
2014
|
|
9 |
p. 14-15
|
article
|
| 98 |
Success with Self-monitoring: Results from the TASMIN-SR Trial
|
Cunningham, Muriel
|
|
2013
|
|
9 |
p. 11-12
|
article
|
| 99 |
Symptom Recognition of AMI among Patients Attending Primary Care Facilities in North-Central Trinidad
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 25-25
|
article
|
| 100 |
TARGET: Nasal Delivery of Sumatriptan Powder Improves Functioning in Patients With Migraine
|
Vinall, Maria
|
|
2015
|
|
9 |
p. 7-7
|
article
|
| 101 |
Teriflunomide Associated With Reductions in Severe MS Relapses
|
Summers, Jaye
|
|
2015
|
|
9 |
p. 17-18
|
article
|
| 102 |
The Association between Arterial Stiffness and LV Diastolic Function in T2DM: 8-Year Follow-up to the Hoorn Study
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 23-24
|
article
|
| 103 |
The ASTIS Trial: First Results
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 8-8
|
article
|
| 104 |
The Benefits of a PCI Registry: An Update
|
Buckley, Rita
|
|
2011
|
|
9 |
p. 17-20
|
article
|
| 105 |
The Changing Landscape of Epilepsy
|
Parry, Nicola
|
|
2015
|
|
9 |
p. 4-5
|
article
|
| 106 |
The Future of Antidiabetic Drug Development: GPR40-Selective Agonist TAK-875
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 35-36
|
article
|
| 107 |
The Left Atrial Appendage and Atrial Fibrillation
|
Vinall, Maria
|
|
2014
|
|
9 |
p. 9-12
|
article
|
| 108 |
The Lifetime Risk of Nephropathy and Its Progression May Be Greater than Previously Reported
|
Vinall, Maria
|
|
2010
|
|
9 |
p. 22-23
|
article
|
| 109 |
The Metabolic Consequences of CHF
|
Gordon, Debra
|
|
2010
|
|
9 |
p. 14-15
|
article
|
| 110 |
The Occurrence of LVH in Normotensive Individuals in a Community Setting in Northeast Trinidad
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 24-25
|
article
|
| 111 |
Towards Imaging Remission: Determining an MRI Inflammatory Activity-Acceptable State in RA
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 21-22
|
article
|
| 112 |
Treating Atrial Fibrillation
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 28-29
|
article
|
| 113 |
Treatment of Acute Coronary Syndrome
|
Vinall, Maria
|
|
2011
|
|
9 |
p. 30-32
|
article
|
| 114 |
Treatment of Arrhythmias and HF with Autonomic Modulation
|
Mosley, Mary
|
|
2014
|
|
9 |
p. 32-33
|
article
|
| 115 |
Update on ACR/EULAR RA Classification Criteria: What Have We Learned?
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 23-25
|
article
|
| 116 |
24-Week Data from the Phase 4 ADACTA Trial
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 10-11
|
article
|
| 117 |
24-Week Results from the RAPID-PsA Study
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 8-9
|
article
|
| 118 |
12-Week Results of a Phase 2b Dose-Ranging Study of Baricitinib (LY3009104) in Combination with Traditional DMARDs in Patients with RA
|
Vinall, Maria
|
|
2012
|
|
9 |
p. 13-14
|
article
|
| 119 |
2-Year Results from the GO-RAISE Trial
|
Rizzo, Toni
|
|
2012
|
|
9 |
p. 17-18
|
article
|
Journal description